| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.935 | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 5.935 | 0 | 571 | 0 | 0 | -509 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 9.998 | 4.360 | 6.300 | 1.171 | 446 | 52 | 51 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -4.063 | -4.360 | -5.729 | -1.171 | -446 | -560 | -51 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -4.240 | -4.360 | -5.730 | -1.171 | -446 | -560 | -51 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Apiculum Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.441 | 7.187 | 1.459 | 358 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 267 | 159 | 591 | 580 | 516 | -2 | -2 | -2 | -2 | 8 |
| Inventories | 0 | 0 | 539 | 529 | 518 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 267 | 159 | 53 | 52 | -2 | -2 | -2 | -2 | -2 | 8 |
| Shareholders Funds | -15.834 | -20.032 | -25.423 | -26.127 | -26.067 | -26.133 | -25.604 | -25.684 | -25.606 | -25.463 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 26.541 | 27.378 | 27.473 | 27.066 | 26.584 | 26.131 | 25.602 | 25.682 | 25.604 | 25.471 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "149 - 149" | |||||||||
| CAEN Financial Year |
149
|
|||||||||
Comments - Apiculum Srl